India's DRDO With Dr Reddy Develop Anti-Covid19 Drugs For Faster Recovery

Amid the exploding Covid19 cases in country, DCGI approves anti-COVID drug developed by DRDO for emergency use. As per Institute of Nuclear Medicine and Allied Sciences, clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.